Teladoc Health Inc (TDOC) President Peter A. Mcclennen Sells 69,224 Shares
Teladoc Health Inc (NYSE:TDOC) President Peter A. Mcclennen sold 69,224 shares of Teladoc Health stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $66.77, for a total value of $4,622,086.48. Following the completion of the sale, the president now directly owns 12,692 shares in the company, valued at approximately $847,444.84. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Shares of NYSE TDOC traded down $2.24 during midday trading on Thursday, hitting $66.04. 538,717 shares of the company’s stock were exchanged, compared to its average volume of 2,131,163. The company has a current ratio of 8.99, a quick ratio of 8.99 and a debt-to-equity ratio of 0.40. Teladoc Health Inc has a 12 month low of $27.30 and a 12 month high of $89.05. The company has a market capitalization of $4.45 billion, a P/E ratio of -40.02 and a beta of 0.96.
Teladoc Health (NYSE:TDOC) last issued its earnings results on Thursday, November 1st. The health services provider reported ($0.34) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.36) by $0.02. Teladoc Health had a negative return on equity of 14.05% and a negative net margin of 31.32%. The company had revenue of $111.00 million during the quarter, compared to the consensus estimate of $109.94 million. During the same period in the previous year, the company posted ($0.55) EPS. The firm’s revenue for the quarter was up 61.6% compared to the same quarter last year. Analysts predict that Teladoc Health Inc will post -1.47 EPS for the current fiscal year.
TDOC has been the topic of a number of recent research reports. Canaccord Genuity reissued a “buy” rating and issued a $70.00 target price (up previously from $63.00) on shares of Teladoc Health in a research report on Wednesday, July 25th. Citigroup lifted their target price on Teladoc Health to $80.00 and gave the company a “buy” rating in a research report on Thursday, July 19th. Jefferies Financial Group set a $74.00 target price on Teladoc Health and gave the company a “buy” rating in a research report on Wednesday, July 11th. SunTrust Banks boosted their price target on Teladoc Health to $77.00 and gave the stock a “buy” rating in a research report on Thursday, August 9th. Finally, Chardan Capital boosted their price target on Teladoc Health from $73.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday, August 3rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $82.95.
WARNING: “Teladoc Health Inc (TDOC) President Peter A. Mcclennen Sells 69,224 Shares” was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://www.dailypolitical.com/2018/11/08/teladoc-health-inc-tdoc-president-peter-a-mcclennen-sells-69224-shares.html.
About Teladoc Health
Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Featured Article: Why investors pay attention to retained earnings
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.